Yohei Sakai
Overview
Explore the profile of Yohei Sakai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishizuka K, Shikino K, Takada N, Sakai Y, Ototake Y, Kobayashi T, et al.
BMC Med Educ
. 2025 Feb;
25(1):221.
PMID: 39934738
Background: Clinical reasoning skills are essential competencies for medical students; therefore, effective, evidence-informed teaching methodologies are needed worldwide. This study investigated the benefits of team-based learning (TBL) for developing the...
2.
Sakai Y, Ochi H, Tanaka M
Microorganisms
. 2022 Sep;
10(9).
PMID: 36144321
Oral administration of a low dose of lactulose increases the abundance of genus in the large intestine; however, the details of the daily variation in have not been researched. To...
3.
Kondo N, Sakai Y, Kakutani R, Netsu T, Kijima Y, Kudo N, et al.
J Dermatol
. 2021 Aug;
48(11):1724-1730.
PMID: 34368990
Pustulotic arthro-osteitis (PAO) is a major complication of palmoplantar pustulosis (PPP). In orthopedic surgery outpatient clinics, PPP patients with osteoarticular symptoms are seen frequently, but PAO's clinical features remain not...
4.
Yoshida K, Hirano R, Sakai Y, Choi M, Sakanaka M, Kurihara S, et al.
Commun Biol
. 2021 May;
4(1):541.
PMID: 33972677
This study aims to understand the mechanistic basis underlying the response of Bifidobacterium to lactulose ingestion in guts of healthy Japanese subjects, with specific focus on a lactulose transporter. An...
5.
Sakai Y, Seki N, Hamano H, Ochi H, Abe F, Shimizu F, et al.
Biosci Microbiota Food Health
. 2019 May;
38(2):69-72.
PMID: 31106110
To investigate the prebiotic effect of lactulose at low dosages, we assessed changes in defaecation frequency following ingestion of 1, 2, or 3 g/day of lactulose for 2 weeks. Each...
6.
Sakai Y, Yoshida T, Shibutani M, Ohmori K
JFMS Open Rep
. 2018 Aug;
4(2):2055116918786601.
PMID: 30083372
Case Summary: A spayed female mixed breed cat of unknown age (presumably more than 9 years old), weighing 2.9 kg, was presented with a 4 day history of lethargy, anorexia...
7.
Sakai Y
Clin Calcium
. 2018 Mar;
28(4):513-517.
PMID: 29593138
Lactulose is a non-digestible oligosaccharide, consisting of galactose and fructose. Bifidobacteria in the large intestine assimilate and metabolize lactulose, which has not been degraded or absorbed by humans, and they...
8.
Misaki R, Sakai Y, Omasa T, Fujiyama K, Seki T
J Biosci Bioeng
. 2011 Aug;
112(5):476-84.
PMID: 21802986
Recombinant DNA technology enables the use of plants as the host for the production of pharmaceutical proteins, such as antibodies. The glycosylation of recombinant proteins plays physiological and biological roles....
9.
Konishi E, Sakai Y, Kitai Y, Yamanaka A
Am J Trop Med Hyg
. 2009 May;
80(5):856-61.
PMID: 19407137
Japanese encephalitis virus (JEV) is maintained through a transmission cycle between amplifier swine and vector mosquitoes in a peridomestic environment. Thus, studies on natural JEV activities in an environment with...
10.
Fujiyama K, Misaki R, Sakai Y, Omasa T, Seki T
J Biosci Bioeng
. 2009 Feb;
107(2):165-72.
PMID: 19217555
The production of antibodies using plants as bioreactors has been realized. Because sugar chain structures on recombinant proteins are a cause of concern, remodeling technology is highly promising. Localizing recombinant...